Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Indivior PLC (INDV)
NASDAQ:INDV
Holding INDV?
Track your performance easily
INDV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.33 - $23.22
Previous Close$10.58
Volume1.00M
Average Volume (3M)1.15M
Market Cap
$1.32B
Enterprise Value$1.16B
Total Cash (Recent Filing)£410.00M
Total Debt (Recent Filing)£282.00M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Feb 13, 2025EPS Estimate
$0.26Last Dividend Ex-Date
Jun 16, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding129,575,205
10 Day Avg. Volume1,434,733
30 Day Avg. Volume1,147,182
Standard Deviation0.14
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-11.38
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)21.40
P/FCF Ratio15.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$19.97Price Target Upside85.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Indivior News
PremiumCompany Announcements
Indivior PLC Executes Strategic Share Repurchase
PremiumCompany Announcements
Indivior’s Voting Rights Shift with Madison Avenue
PremiumCompany Announcements
Indivior Extends Board Tenure Amidst Shareholder ChangesBulls Say, Bears Say
Bulls Say
Market OpportunityThere is still a large market opportunity for both Sublocade and Brixadi to become >$1bn products.
Market ValuationIndivior is seen as a business generating strong cash flows and trading at low market multiples, suggesting the market is overly discounting the prospects of Sublocade.
Product EfficacyThe superior once-monthly efficacy profile of Sublocade is expected to win over the medium term despite current challenges.
Bears Say
Competitive PressureOngoing Brixadi competition and further destocking are expected to negatively impact Sublocade's sales in the coming quarters.
Profitability ConcernsIndivior's second profit warning of 2024, confirming strengthening Brixadi competitive headwinds, prompts a significant reduction in estimates and recognition that market confidence has been dented.
Sales ImpactProfit warning issued due to lower-than-expected Sublocade revenues, with significant competition from Brixadi in CJS markets impacting sales.
---
Ownership Overview
4.94% Insiders
3.60% Mutual Funds
35.14% Other Institutional Investors
52.19% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INDV FAQ
What was Indivior PLC’s price range in the past 12 months?
Indivior PLC lowest stock price was $7.33 and its highest was $23.22 in the past 12 months.
What is Indivior PLC’s market cap?
Currently, no data Available
When is Indivior PLC’s upcoming earnings report date?
Indivior PLC’s upcoming earnings report date is Feb 13, 2025 which is in 83 days.
How were Indivior PLC’s earnings last quarter?
Indivior PLC released its earnings results on Oct 24, 2024. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.407 by $0.133.
Is Indivior PLC overvalued?
According to Wall Street analysts Indivior PLC’s price is currently Undervalued.
Does Indivior PLC pay dividends?
Indivior PLC pays a Notavailable dividend of $0.49 which represents an annual dividend yield of N/A. See more information on Indivior PLC dividends here
What is Indivior PLC’s EPS estimate?
Indivior PLC’s EPS estimate is $0.26.
How many shares outstanding does Indivior PLC have?
Indivior PLC has 128,207,700 shares outstanding.
What happened to Indivior PLC’s price movement after its last earnings report?
Indivior PLC reported an EPS of $0.54 in its last earnings report, beating expectations of $0.407. Following the earnings report the stock price went up 2.453%.
Which hedge fund is a major shareholder of Indivior PLC?
Currently, no hedge funds are holding shares in INDV
---
Indivior Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.97 (85.58% Upside)
$19.97 (85.58% Upside)
Blogger Sentiment
Bullish
INDV Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.77%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-28.07%
Trailing 12-Months
Company Description
Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
---
INDV Stock 12 Month Forecast
Average Price Target
$19.97
▲(85.58% Upside)
Technical Analysis
Best Analysts Covering INDV
1 Year
1 Year Success Rate
3/7 ratings generated profit
1 Year Average Return
-5.79%
reiterated a buy rating 17 days ago
Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -5.79% per trade.
---